488 related articles for article (PubMed ID: 30843002)
1. The role of
Ayubcha C; Hosoya H; Seraj SM; Zadeh MZ; Werner T; Alavi A
Hell J Nucl Med; 2019; 22(1):4-5. PubMed ID: 30843002
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. Abass Alavi: A giant in Nuclear Medicine turns 80 and is still going strong!
Høilund-Carlsen PF
Hell J Nucl Med; 2018; 21(1):85-87. PubMed ID: 29550853
[TBL] [Abstract][Full Text] [Related]
4. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging based bone marrow segmentation for quantitative calculation of pure red marrow metabolism using 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography: a novel application with significant implications for combined structure-function approach.
Basu S; Houseni M; Bural G; Chamroonat W; Udupa J; Mishra S; Alavi A
Mol Imaging Biol; 2007; 9(6):361-5. PubMed ID: 17899296
[TBL] [Abstract][Full Text] [Related]
6. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
7. Detection by (18)F-FDG PET of unsuspected extensive bone marrow metastases in a case of basosquamous carcinoma of the cheek.
Joshi P; Kulkarni MJ; Abhyankar A; Shet T; Basu S
Hell J Nucl Med; 2011; 14(3):307-8. PubMed ID: 22087455
[TBL] [Abstract][Full Text] [Related]
8. Age-related changes in the metabolic activity and distribution of the red marrow as demonstrated by 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography.
Fan C; Hernandez-Pampaloni M; Houseni M; Chamroonrat W; Basu S; Kumar R; Dadparvar S; Torigian DA; Alavi A
Mol Imaging Biol; 2007; 9(5):300-7. PubMed ID: 17574502
[TBL] [Abstract][Full Text] [Related]
9. A Pilot Study of FDG-PET/CT in Polycythemia Vera Using Global Analysis Techniques.
Ayubcha C; Hosoya H; Mehdizadeh Seraj S; Zirakchian Zadeh M; M S E TW; Alavi A
Asia Ocean J Nucl Med Biol; 2020; 8(1):64-68. PubMed ID: 32064285
[TBL] [Abstract][Full Text] [Related]
10. Discordant findings in patients with non-small-cell lung cancer: absolutely normal bone scans versus disseminated bone metastases on positron-emission tomography/computed tomography.
Ak I; Sivrikoz MC; Entok E; Vardareli E
Eur J Cardiothorac Surg; 2010 Apr; 37(4):792-6. PubMed ID: 20015657
[TBL] [Abstract][Full Text] [Related]
11. [
Dyall J; Johnson RF; Chefer S; Leyson C; Thomasson D; Seidel J; Ragland DR; Byrum R; Jett C; Cann JA; St Claire M; Jagoda E; Reba RC; Hammoud D; Blaney JE; Jahrling PB
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814515
[TBL] [Abstract][Full Text] [Related]
12. Dual-time point
Parghane RV; Basu S
Semin Nucl Med; 2017 Jul; 47(4):373-391. PubMed ID: 28583277
[TBL] [Abstract][Full Text] [Related]
13. Clinical Application of
Zirakchian Zadeh M
Clin Lymphoma Myeloma Leuk; 2023 Nov; 23(11):800-814. PubMed ID: 37558532
[TBL] [Abstract][Full Text] [Related]
14. Increased (18)F-fluorodeoxyglucose uptake in benign, nonphysiologic lesions found on whole-body positron emission tomography/computed tomography (PET/CT): accumulated data from four years of experience with PET/CT.
Metser U; Even-Sapir E
Semin Nucl Med; 2007 May; 37(3):206-22. PubMed ID: 17418153
[TBL] [Abstract][Full Text] [Related]
15. F-18 FDG uptake of bone marrow on PET/CT scan: it's correlation with CD38/CD138 expressing myeloma cells in bone marrow of patients with multiple myeloma.
Ak I; Gulbas Z
Ann Hematol; 2011 Jan; 90(1):81-7. PubMed ID: 20690019
[TBL] [Abstract][Full Text] [Related]
16.
Faivre L; Chaussard M; Vercellino L; Vanneaux V; Hosten B; Teixera K; Parietti V; Merlet P; Sarda-Mantel L; Rizzo-Padoin N; Larghero J
Curr Res Transl Med; 2016; 64(3):141-148. PubMed ID: 27765274
[TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET/CT, 99mTc-MIBI, and MRI in evaluation of patients with multiple myeloma.
Fonti R; Salvatore B; Quarantelli M; Sirignano C; Segreto S; Petruzziello F; Catalano L; Liuzzi R; Rotoli B; Del Vecchio S; Pace L; Salvatore M
J Nucl Med; 2008 Feb; 49(2):195-200. PubMed ID: 18199607
[TBL] [Abstract][Full Text] [Related]
18. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
19. Sickle cell diseases: What can nuclear medicine offer?
Niccoli Asabella A; Altini C; Nappi AG; Lavelli V; Ferrari C; Marzullo A; Loiodice A; Rubini G
Hell J Nucl Med; 2019; 22(1):2-3. PubMed ID: 30843001
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]